Literature DB >> 24370891

A potential role for GPR55 in the regulation of energy homeostasis.

Anna C Simcocks1, Lannie O'Keefe1, Kayte A Jenkin1, Michael L Mathai2, Deanne H Hryciw3, Andrew J McAinch4.   

Abstract

G protein-coupled receptor 55 (GPR55) is a putative cannabinoid receptor that is expressed in several tissues involved in regulating energy homeostasis, including the hypothalamus, gastrointestinal tract, pancreas, liver, white adipose and skeletal muscle. GPR55 has been shown to have a role in cancer and gastrointestinal inflammation, as well as in obesity and type 2 diabetes mellitus (T2DM). Despite this, the (patho)physiological role of GPR55 in cell dysfunction is still poorly understood, largely because of the limited identification of downstream signalling targets. Nonetheless, research has suggested that GPR55 modulation would be a useful pharmacological target in metabolically active tissues to improve treatment of diseases such as obesity and T2DM. Further research is essential to gain a better understanding of the role that this receptor might have in these and other pathophysiological conditions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370891     DOI: 10.1016/j.drudis.2013.12.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  14 in total

1.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

Review 2.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

3.  Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity.

Authors:  A Meadows; J H Lee; C-S Wu; Q Wei; G Pradhan; M Yafi; H-C Lu; Y Sun
Journal:  Int J Obes (Lond)       Date:  2015-10-08       Impact factor: 5.095

4.  Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.

Authors:  Mirko Lanuti; Emanuela Talamonti; Mauro Maccarrone; Valerio Chiurchiù
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

Review 5.  The therapeutic potential of orphan GPCRs, GPR35 and GPR55.

Authors:  Derek M Shore; Patricia H Reggio
Journal:  Front Pharmacol       Date:  2015-04-15       Impact factor: 5.810

Review 6.  Lysophosphatidylinositol Signalling and Metabolic Diseases.

Authors:  Syamsul A Arifin; Marco Falasca
Journal:  Metabolites       Date:  2016-01-15

Review 7.  Advances in the Physiology of GPR55 in the Central Nervous System.

Authors:  Bruno A Marichal-Cancino; Alfonso Fajardo-Valdez; Alejandra E Ruiz-Contreras; Monica Mendez-Díaz; Oscar Prospero-García
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Roles of G protein-coupled receptors in inflammatory bowel disease.

Authors:  Zhen Zeng; Arjudeb Mukherjee; Adwin Pidiyath Varghese; Xiao-Li Yang; Sha Chen; Hu Zhang
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

9.  Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation.

Authors:  Mikael Bjursell; Erik Ryberg; Tingting Wu; Peter J Greasley; Mohammad Bohlooly-Y; Stephan Hjorth
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

Review 10.  Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.

Authors:  Ken Soderstrom; Eman Soliman; Rukiyah Van Dross
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.